The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Donor-Derived Ip-10 Initiates Development of Acute Allograft Rejection
Open accessAbstract
An allograft is often considered an immunologically inert playing field on which host leukocytes assemble and wreak havoc. However, we demonstrate that graft-specific physiologic responses to early injury initiate and promulgate destruction of vascularized grafts. Serial analysis of allografts showed that intragraft expression of the three chemokine ligands for the CXC chemo-kine receptor CXCR3 was induced in the order of interferon (IFN)-γ–inducible protein of 10 kD (IP-10, or CXCL10), IFN-inducible T cell α-chemoattractant (I-TAC; CXCL11), and then monokine induced by IFN-γ (Mig, CXCL9). Initial IP-10 production was localized to endothelial cells, and only IP-10 was induced by isografting. Anti–IP-10 monoclonal antibodies prolonged allograft survival, but surprisingly, IP-10–deficient (IP-10−/−) mice acutely rejected allografts. However, though allografts from IP-10+/+ mice were rejected by day 7, hearts from IP-10−/− mice survived long term. Compared with IP-10+/+ donors, use of IP-10−/− donors reduced intragraft expression of cytokines, chemokines and their receptors, and associated leukocyte infiltration and graft injury. Hence, tissue-specific generation of a single chemokine in response to initial ischemia/reperfusion can initiate progressive graft infiltration and amplification of multiple effector pathways, and targeting of this proximal chemokine can prevent acute rejection. These data emphasize the pivotal role of donor-derived IP-10 in initiating alloresponses, with implications for tissue engineering to decrease immunogenicity, and demonstrate that chemokine redundancy may not be operative in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bonecchi, R., Bianchi, G., Bordignon, P. P., D'Ambrosio, D., Lang, R., Borsatti, A., Sozzani, S., Allavena, P., Gray, P. A., Mantovani, A., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.1.129 · Cited by 2,014
International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors
Murphy, P. M., Baggiolini, M., Charo, I. F., Hébert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J., & Power, C. A. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01439-x · Cited by 1,817
Qin, S., Rottman, J. B., Myers, P., Kassam, N., Weinblatt, M., Loetscher, M., Koch, A. E., Moser, B., & Mackay, C. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1422 · Cited by 1,359 · cited 1×
“Since CXCR3 is primarily expressed by NK cells and activated T cells (14), we assessed the numbers of each of these cell types.”
BackgroundLoetscher, M., Gerber, B., Loetscher, P., Jones, S. A., Piali, L., Clark-Lewis, I., Baggiolini, M., & Moser, B. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.963 · Cited by 1,193
Luster, A. D., Unkeless, J. C., & Ravetch, J. V. (1985) · Nature · doi:10.1038/315672a0 · Cited by 944
Self-citationCole, K. E., Strick, C. A., Paradis, T. J., Ogborne, K. T., Loetscher, M., Gladue, R. P., Lin, W., Boyd, J. G., Moser, B., Wood, D. E., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.2009 · Cited by 870
Requirement of the Chemokine Receptor CXCR3 for Acute Allograft Rejection
Hancock, W. W., Lu, B., Gao, W., Csizmadia, V., Faia, K., King, J. A., Smiley, S. T., Ling, M., Gerard, N. P., & Gerard, C. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.10.1515 · Cited by 617
Self-citationHancock, W. W., Buelow, R., Sayegh, M. H., & Turka, L. A. (1998) · Nature Medicine · doi:10.1038/3982 · Cited by 453
Self-citationHancock, W. W., Sayegh, M. H., Zheng, X.-G., Peach, R., Linsley, P. S., & Turka, L. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13967 · Cited by 411
Self-citationFarber, J. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5238 · Cited by 298
Cited by
Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
Griffith, J. W., Sokol, C. L., & Luster, A. D. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120145 · Cited by 2,059
Self-citationDufour, J. H., Dziejman, M., Liu, M. T., Leung, J. H., Lane, T. E., & Luster, A. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3195 · Cited by 1,075
Self-citationCXCR3 ligands: redundant, collaborative and antagonistic functions
Groom, J. R., & Luster, A. D. (2011) · Immunology & Cell Biology · doi:10.1038/icb.2010.158 · Cited by 1,001
Self-citationGroom, J. R., & Luster, A. D. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.12.017 · Cited by 988
Self-citationThe Chemokine System in Innate Immunity
Sokol, C. L., & Luster, A. D. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016303 · Cited by 862
Self-citationBachelerie, F., Ben-Baruch, A., Burkhardt, A. M., Combadiere, C., Farber, J. M., Graham, G. J., Horuk, R., Sparre-Ulrich, A. H., Locati, M., Luster, A. D., et al. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.007724 · Cited by 850
Self-citationChow, M. T., Ozga, A. J., Servis, R. L., Frederick, D. T., Lo, J. A., Fisher, D. E., Freeman, G. J., Boland, G. M., & Luster, A. D. (2019) · Immunity · doi:10.1016/j.immuni.2019.04.010 · Cited by 716
“CXCR3 and its ligands guide the recruitment of effector T cells into the inflamed peripheral tissue in type 1 inflammatory responses (Dufour et al., 2002; Hancock et al., 2001; Hancock et al., 2000; Harris et al., 2012; Khan et al., 2000; Rashighi et al., 2014).”
Self-citationThe role of chemokines in linking innate and adaptive immunity
Luster, A. D. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(01)00308-9 · Cited by 474
Self-citationNeuronal CXCL10 Directs CD8 + T-Cell Recruitment and Control of West Nile Virus Encephalitis
Klein, R. S., Lin, E., Zhang, B., Luster, A. D., Tollett, J., Samuel, M. A., Engle, M., & Diamond, M. S. (2005) · Journal of Virology · doi:10.1128/jvi.79.17.11457-11466.2005 · Cited by 424
“CXCL10 has been shown to affect the expression of interferon gamma (18) and influence the development of antigen-driven Th1 responses.”
BackgroundSelf-citationThe emerging role of CXCL10 in cancer (Review)
LIU, M., GUO, S., & STILES, J. K. (2011) · Oncology Letters · doi:10.3892/ol.2011.300 · Cited by 411
Hanna, J., Wald, O., Goldman-Wohl, D., Prus, D., Markel, G., Gazit, R., Katz, G., Haimov-Kochman, R., Fujii, N., Yagel, S., et al. (2003) · Blood · doi:10.1182/blood-2003-02-0517 · Cited by 346
Chemokines in the systemic organization of immunity
Campbell, D. J., Kim, C. H., & Butcher, E. C. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00067.x · Cited by 330
Importance of ICOS–B7RP-1 costimulation in acute and chronic allograft rejection
Özkaynak, E., Gao, W., Shemmeri, N., Wang, C., Gutierrez-Ramos, J.-C., Amaral, J., Qin, S., Rottman, J. B., Coyle, A. J., & Hancock, W. W. (2001) · Nature Immunology · doi:10.1038/89731 · Cited by 317
Self-citationIchikawa, A., Kuba, K., Morita, M., Chida, S., Tezuka, H., Hara, H., Sasaki, T., Ohteki, T., Ranieri, V. M., dos Santos, C. C., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201203-0508oc · Cited by 289
Self-citationIntracellular Domains of CXCR3 That Mediate CXCL9, CXCL10, and CXCL11 Function
Colvin, R. A., Campanella, G. S. V., Sun, J., & Luster, A. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403595200 · Cited by 274
Self-citationRole of Chemokines in Endocrine Autoimmune Diseases
Rotondi, M., Chiovato, L., Romagnani, S., Serio, M., & Romagnani, P. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0044 · Cited by 257
Proinflammatory functions of vascular endothelial growth factor in alloimmunity
Reinders, M. E. J., Sho, M., Izawa, A., Wang, P., Mukhopadhyay, D., Koss, K. E., Geehan, C. S., Luster, A. D., Sayegh, M. H., & Briscoe, D. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17712 · Cited by 251
Self-citationLazzeri, E., Rotondi, M., Mazzinghi, B., Lasagni, L., Buonamano, A., Rosati, A., Pradella, F., Fossombroni, V., La Villa, G., Gacci, M., et al. (2005) · Transplantation · doi:10.1097/01.tp.0000160759.85080.2e · Cited by 96
Rotondi, M., Rosati, A., Buonamano, A., Lasagni, L., Lazzeri, E., Pradella, F., Fossombroni, V., Cirami, C., Liotta, F., La Villa, G., et al. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00525.x · Cited by 92
Rosenblum, J. M., Shimoda, N., Schenk, A. D., Zhang, H., Kish, D. D., Keslar, K., Farber, J. M., & Fairchild, R. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903831 · Cited by 80
Metadata
- Authors
- Hancock, W. W., Gao, W., Csizmadia, V., Faia, K. L., Shemmeri, N., & Luster, A. D.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2001-04-16
- Volume
- 193
- Issue
- 8
- Pages
- 975-980
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2116493322
- Cited by
- 373
- References
- 22
- FWCI
- 36.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.